Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,258	3,226	2,801	2,165	2,177	1,975
Cash & Short-Term Investments	2,258	3,226	2,801	2,165	2,177	1,975
Cash Growth	-15.40%	15.17%	29.38%	-0.55%	10.23%	10.83%
Receivables	3,766	3,408	3,696	4,529	4,581	5,676
Inventory	3,927	4,021	3,833	3,818	4,403	4,422
Prepaid Expenses	1,096	1,255	1,162	1,075	945	870
Restricted Cash	-	1	33	33	-	-
Other Current Assets	585	574	526	953	899	521
Total Current Assets	11,632	12,485	12,051	12,573	13,005	13,464
Property, Plant & Equipment	5,931	6,147	6,158	6,477	6,855	6,950
Long-Term Investments	-	8	-	-	-	-
Goodwill	16,488	17,177	17,633	20,040	20,624	24,846
Other Intangible Assets	4,853	5,387	6,270	7,466	8,923	11,232
Long-Term Deferred Tax Assets	2,000	1,812	1,458	596	695	386
Other Long-Term Assets	434	463	441	514	538	592
Total Assets	41,338	43,479	44,011	47,666	50,640	57,470
Accounts Payable	2,366	2,602	1,887	1,686	1,756	1,718
Accrued Expenses	5,638	5,525	4,955	5,280	5,347	6,566
Current Portion of Long-Term Debt	2,094	1,672	2,109	1,426	3,188	2,345
Current Portion of Leases	-	97	93	109	116	118
Other Current Liabilities	2,939	2,351	2,425	2,526	2,757	2,927
Total Current Liabilities	13,037	12,247	11,469	11,027	13,164	13,674
Long-Term Debt	16,547	18,161	19,103	21,617	22,731	24,562
Long-Term Leases	281	343	371	441	500	435
Long-Term Deferred Tax Liabilities	553	606	548	784	964	1,096
Other Long-Term Liabilities	4,357	3,996	3,922	2,553	2,220	2,640
Total Liabilities	34,775	35,353	35,413	36,422	39,579	42,407
Common Stock	58	57	57	57	57	56
Additional Paid-In Capital	27,829	27,807	27,688	27,561	27,443	27,312
Retained Earnings	-14,519	-13,534	-12,975	-10,529	-10,946	-6,956
Treasury Stock	-4,128	-4,128	-4,128	-4,128	-4,128	-4,128
Comprehensive Income & Other	-2,881	-2,696	-2,838	-2,683	-2,400	-2,312
Total Common Equity	6,359	7,506	7,804	10,278	10,026	13,972
Minority Interest	204	620	794	966	1,035	1,091
Shareholders' Equity	6,563	8,126	8,598	11,244	11,061	15,063
Total Liabilities & Equity	41,338	43,479	44,011	47,666	50,640	57,470
Total Debt	18,922	20,273	21,676	23,593	26,535	27,460
Net Cash (Debt)	-16,664	-17,047	-18,875	-21,428	-24,358	-25,485
Net Cash Per Share	-14.83	-15.23	-17.00	-19.36	-22.24	-23.36
Filing Date Shares Outstanding	1,133	1,121	1,111	1,103	1,097	1,092
Total Common Shares Outstanding	1,133	1,121	1,111	1,103	1,097	1,092
Working Capital	-1,405	238	582	1,546	-159	-210
Book Value Per Share	5.61	6.70	7.02	9.32	9.14	12.79
Tangible Book Value	-14,982	-15,058	-16,099	-17,228	-19,521	-22,106
Tangible Book Value Per Share	-13.22	-13.43	-14.49	-15.61	-17.80	-20.24
Land	-	246	246	262	292	323
Buildings	-	2,488	2,463	2,568	2,720	2,839
Machinery	-	7,226	7,349	7,359	7,443	7,516
Construction In Progress	-	1,427	1,199	1,034	933	672

Source: S&P Capital IQ. Standard template. Financial Sources.